Propofol-Ketamine (Ketofol) Infusion for Pediatric Surgery Without Neuromuscular Blockade
Yes, propofol-ketamine (ketofol) infusion can be safely used for pediatric surgery without neuromuscular blockers, particularly for shorter procedures, with appropriate dosing, monitoring, and airway management expertise.
Key Considerations for Safe Use
Age and Indication Restrictions
Propofol is FDA-approved for:
Propofol is not indicated for pediatric ICU sedation or MAC sedation for procedures, as safety has not been established in these contexts 1. However, general anesthesia for surgery is an approved indication.
Recommended Dosing Regimens
For procedures lasting 30-90 minutes:
- Ketamine:Propofol ratio of 1:5 to 1:7 is optimal for anesthesia 2
- 1:5 ratio for 30-minute procedures
- 1:6.7 ratio for 90-minute procedures
- These ratios maintain propofol antiemetic concentrations longer than ketamine analgesic concentrations
Induction:
- Ketofol 1:4 ratio: 0.1 mL/kg in children 2-11 years 3
- Standard propofol induction: 2.5-3.5 mg/kg for ASA I-II patients 1
Maintenance:
- Ketofol 1:7 ratio using modified McFarlan dosing: 1.5,1.3, and 1.1 mL/kg/h for 15, and 30 minutes respectively 4
- Infusion rates must be reduced by 20-80% compared to propofol-only regimens to avoid prolonged recovery 2
Clinical Advantages Without Neuromuscular Blockade
The ketofol combination offers several benefits that make it suitable for surgery without relaxants:
- Reduced propofol requirements by approximately 40% 4, 5
- Reduced opioid requirements by 50% 4
- Faster extubation times: 240 seconds vs 530 seconds with propofol alone 4
- Shorter PACU stays: 35 minutes vs 100 minutes 4
- Lower hypotension risk compared to fentanyl-propofol combinations 6
- Maintained spontaneous ventilation due to ketamine's respiratory drive preservation
Critical Safety Monitoring
Essential monitoring per AAP/ASA guidelines 7:
- Continuous pulse oximetry
- Continuous capnography (mandatory for deep sedation/anesthesia)
- ECG monitoring
- Blood pressure every 3-5 minutes
- Clinical observation by dedicated provider
Specific concerns with propofol in pediatrics 1:
- Bradycardia risk when combined with fentanyl (avoid or use cautiously)
- Respiratory depression requiring immediate airway management capability
- Propofol infusion syndrome (rare but serious with prolonged infusions)
Airway Management Requirements
Without neuromuscular blockade, you must:
- Have advanced airway skills readily available
- Be prepared for bag-mask ventilation, LMA placement, or intubation 7
- Ensure adequate depth to prevent laryngospasm while maintaining spontaneous ventilation
- Consider regional anesthesia as adjunct to reduce systemic drug requirements 8
Common Pitfalls to Avoid
- Excessive ketamine ratios (>1:3) delay recovery beyond 20 minutes 3, 2
- Standard propofol infusion rates when using ketofol cause prolonged sedation—reduce rates by 20-80% depending on ratio 2
- Rapid bolus administration in elderly/debilitated patients causes severe cardiorespiratory depression 1
- Inadequate monitoring of respiratory status—capnography is essential 7
- Use in upper respiratory infections—associated with serious adverse events in pediatric ICU settings 1
Contraindications and Cautions
Avoid ketofol in:
- Children <2 months for maintenance, <3 years for induction 1
- Active upper respiratory tract infections 1
- Situations requiring deep neuromuscular blockade for surgical exposure
Use reduced doses in:
- ASA III-IV patients: 1-1.5 mg/kg propofol for induction 1
- Cardiac patients: slow induction at 20 mg every 10 seconds 1
Adjunctive Strategies
Enhance safety and efficacy by:
- Regional anesthesia as primary analgesic technique with ketofol for sedation/amnesia 8, 9
- Dexamethasone 0.1-0.15 mg/kg for PONV prophylaxis and prolonged analgesia 8
- Alpha-2 agonists for additional opioid-sparing and reduced emergence agitation 8
- Multimodal analgesia with NSAIDs/acetaminophen to minimize opioid requirements 8
Recovery Considerations
Expect:
- Rapid eye opening: mean 5 minutes (range 0-17 minutes) 9
- Potential for agitation, tremulousness, hyperirritability with abrupt discontinuation after prolonged infusions 1
- Higher incidence of jitteriness (9%) and agitation (4%) compared to other agents 1
The evidence strongly supports ketofol for pediatric surgery without relaxants when used with appropriate ratios (1:5 to 1:7), reduced infusion rates, comprehensive monitoring including capnography, and immediate airway management capability. 4, 9, 2